American Association for Cancer Research
Browse

sorry, we can't preview this file

crc-22-0117-s01.docx (17.84 kB)

Supplementary Information SI1 from Tumor Cell–Autonomous SHP2 Contributes to Immune Suppression in Metastatic Breast Cancer

Download (17.84 kB)
journal contribution
posted on 2023-04-04, 01:41 authored by Hao Chen, Gregory M. Cresswell, Sarah Libring, Mitchell G. Ayers, Jinmin Miao, Zhong-Yin Zhang, Luis Solorio, Timothy L. Ratliff, Michael K. Wendt

This is the code information for publicly available data analysis.

Funding

HHS | NIH | National Cancer Institute (NCI)

Indiana Clinical and Translational Science Institute

American Cancer Society (ACS)

History

ARTICLE ABSTRACT

Findings present inhibition of SHP2 as a therapeutic option to limit breast cancer metastasis by promoting antitumor immunity.